HEIDI HOFFMAN: Open Payments
NPI 1205826328 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 23 payments from 8 companies in 2025. Trend: 2023 $222 · 2024 $335 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $153 |
| Lilly USA, LLC | 7 | $151 |
| Exact Sciences Corporation | 2 | $41 |
| Amgen Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| PFIZER INC. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
Products named: MOUNJARO, Rybelsus, The Cologuard Plus Collection Kit, OTEZLA, Ozempic, INJECTAFER, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across PA — which companies pay providers there.
